Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Deal Watch: Boehringer Signs On For Rectify’s Chronic Kidney Disease Assets

Dec 23 2025

• By Joseph Haas

Deal Watch 2021 — • Source: Shutterstock

Related Companies

Rectify Pharmaceuticals, Inc.

Boehringer Ingelheim GmbH

GSK plc

CAMP4 Therapeutics Corp.

Sagimet Biosciences

Teva Pharmaceutical Industries Ltd.

Madrigal Pharmaceuticals, Inc.

Valink Therapeutics Ltd

Nona Biosciences

Vir Biotechnology, Inc.

Norgine B.V.

Caris Life Sciences

Genentech, Inc.

Adaptive Biotechnologies Corporation

Pfizer Inc.

XOMA Royalty Corporation

Generation Bio Co.

Tonix Pharmaceuticals Holding Corp.

Rutgers University

Wake Forest University School of Medicine

Hyloris Pharmaceuticals SA

Protalix BioTherapeutics, Inc.

Secarna Pharmaceuticals GmbH & Co. KG

Camurus AB

Gubra ApS

Cadrenal Therapeutics, Inc.

Veralox Therapeutics

Cycle Pharmaceuticals Ltd.

InduPro, Inc.

Sanofi

Moderna, Inc.

Nanexa AB

Profluent

Ensoma

IDEAYA Biosciences, Inc.

Laboratoires Thea

Iolyx Therapeutics Inc.

More from Deal Watch

More from Deals

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window